Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Glimelius

Showing results (111-120 of 416) with videos related to

Pageof 42
Sort By:
Cancer|May 1, 1989
Preoperative prediction of outcome in patients with rectal and rectosigmoid cancerE Ståhle, B Glimelius, R Bergström, et al.
International Journal of Radiation Biology|March 11, 1999
Comparison of cell survival models for mixed LET radiationN Tilly, A Brahme, J Carlsson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canalC Svensson, S Goldman, B Friberg, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
A systematic overview of chemotherapy effects in Hodgkin's diseaseL Brandt, E Kimby, P Nygren, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphomaL Brandt, E Kimby, P Nygren, et al.
Anticancer Research|March 1, 1996
Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancerG Lindmark, U Kressner, R Bergström, et al.
Acta Radiologica. Oncology|January 1, 1983
Radiation therapy of anal carcinomaB Glimelius, S Graffman, L Påhlman, et al.
The British Journal of Surgery|September 13, 2007
Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapyH Birgisson, L Påhlman, U Gunnarsson, et al.
European Journal of Haematology|April 21, 1998
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective studyG Enblad, H Hagberg, A Gustavsson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study GroupG Enblad, B Glimelius, H Hagberg, et al.
Pageof 42

Showing results (111-120 of 416) with videos related to

Sort By:
Pageof 42
Cancer|May 1, 1989
Preoperative prediction of outcome in patients with rectal and rectosigmoid cancerE Ståhle, B Glimelius, R Bergström, et al.
International Journal of Radiation Biology|March 11, 1999
Comparison of cell survival models for mixed LET radiationN Tilly, A Brahme, J Carlsson, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Induction chemotherapy and radiotherapy in loco-regionally advanced epidermoid carcinoma of the anal canalC Svensson, S Goldman, B Friberg, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
A systematic overview of chemotherapy effects in Hodgkin's diseaseL Brandt, E Kimby, P Nygren, et al.
Acta Oncologica (Stockholm, Sweden)|July 10, 2001
A systematic overview of chemotherapy effects in indolent non-Hodgkin's lymphomaL Brandt, E Kimby, P Nygren, et al.
Anticancer Research|March 1, 1996
Limited clinical significance of the serum tumour marker Ca 72-4 in colorectal cancerG Lindmark, U Kressner, R Bergström, et al.
Acta Radiologica. Oncology|January 1, 1983
Radiation therapy of anal carcinomaB Glimelius, S Graffman, L Påhlman, et al.
The British Journal of Surgery|September 13, 2007
Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapyH Birgisson, L Påhlman, U Gunnarsson, et al.
European Journal of Haematology|April 21, 1998
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease: a prospective studyG Enblad, H Hagberg, A Gustavsson, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Methyl-GAG, ifosfamide, methotrexate and etoposide (MIME) as salvage therapy for Hodgkin's disease and non-Hodgkin's lymphoma. The Swedish Lymphoma Study GroupG Enblad, B Glimelius, H Hagberg, et al.
Pageof 42